APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Next-Generation Tumor Genetic Testing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Next-Generation Tumor Genetic Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17419734032 May 2026193 pages

Choose your research edition.

Industry ResearchNext-Generation Tumor Genetic Testing Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Next-Generation Tumor Genetic Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Next-Generation Tumor Genetic Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Next-Generation Tumor Genetic Testing Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Next-Generation Tumor Genetic Testing Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Next-Generation Tumor Genetic Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Next-Generation Tumor Genetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Next-Generation Tumor Genetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Next-Generation Tumor Genetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Next-Generation Tumor Genetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Next-Generation Tumor Genetic Testing include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies and Natera, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Next-Generation Tumor Genetic Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Next-Generation Tumor Genetic Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Next-Generation Tumor Genetic Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Next-Generation Tumor Genetic Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Next-Generation Tumor Genetic Testing Segment by Company

Devyser

Agendia

Illumina

Personal Genome Diagnostics

Veracyte

Pacific Biosciences of California

Qiagen

Agilent Technologies

Natera

Bio Rad Laboratories

Myriad Genetics

Next-Generation Tumor Genetic Testing Segment by Type

Fluorescence In Situ Hybridization

Polymerase Chain Reaction

Microarray Technology

Serum Proteomics

Nucleic Acid Sequencing

Next-Generation Tumor Genetic Testing Segment by Application

Hospitals

Speciality Clinics

Research Institutes

Diagnostics Laboratories

Biopharmaceutical Companies

Next-Generation Tumor Genetic Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next-Generation Tumor Genetic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Next-Generation Tumor Genetic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next-Generation Tumor Genetic Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Next-Generation Tumor Genetic Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next-Generation Tumor Genetic Testing industry.

Chapter 3: Detailed analysis of Next-Generation Tumor Genetic Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Next-Generation Tumor Genetic Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Next-Generation Tumor Genetic Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Fluorescence In Situ Hybridization Table 3. Key Players of Polymerase Chain Reaction Table 4. Key Players of Microarray Technology Table 3. Key Players of Serum Proteomics Table 4. Key Players of Nucleic Acid Sequencing Table 5. Global Next-Generation Tumor Genetic Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospitals Table 7. Key Players of Speciality Clinics Table 8. Key Players of Research Institutes Table 9. Key Players of Diagnostics Laboratories Table 10. Key Players of Biopharmaceutical Companies Table 11. Global Next-Generation Tumor Genetic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Next-Generation Tumor Genetic Testing Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Next-Generation Tumor Genetic Testing Market Share by Region (2021-2026) Table 14. Global Next-Generation Tumor Genetic Testing Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Next-Generation Tumor Genetic Testing Market Share by Region (2027-2032) Table 16. Next-Generation Tumor Genetic Testing Industry Trends Table 17. Next-Generation Tumor Genetic Testing Industry Drivers Table 18. Next-Generation Tumor Genetic Testing Industry Opportunities and Challenges Table 19. Next-Generation Tumor Genetic Testing Industry Restraints Table 20. Global Next-Generation Tumor Genetic Testing Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Company (2021-2026) Table 22. Global Next-Generation Tumor Genetic Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Next-Generation Tumor Genetic Testing Key Company Head Office and Area Served Table 24. Global Next-Generation Tumor Genetic Testing Company, Product Type & Application Table 25. Global Next-Generation Tumor Genetic Testing Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Next-Generation Tumor Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Next-Generation Tumor Genetic Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Type (2021-2026) Table 32. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Type (2027-2032) Table 33. Global Next-Generation Tumor Genetic Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Application (2021-2026) Table 37. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Application (2027-2032) Table 38. Devyser Company Information Table 39. Devyser Business Overview Table 40. Devyser Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Devyser Next-Generation Tumor Genetic Testing Product Portfolio Table 42. Devyser Recent Development Table 43. Agendia Company Information Table 44. Agendia Business Overview Table 45. Agendia Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Agendia Next-Generation Tumor Genetic Testing Product Portfolio Table 47. Agendia Recent Development Table 48. Illumina Company Information Table 49. Illumina Business Overview Table 50. Illumina Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Illumina Next-Generation Tumor Genetic Testing Product Portfolio Table 52. Illumina Recent Development Table 53. Personal Genome Diagnostics Company Information Table 54. Personal Genome Diagnostics Business Overview Table 55. Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product Portfolio Table 57. Personal Genome Diagnostics Recent Development Table 58. Veracyte Company Information Table 59. Veracyte Business Overview Table 60. Veracyte Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Veracyte Next-Generation Tumor Genetic Testing Product Portfolio Table 62. Veracyte Recent Development Table 63. Pacific Biosciences of California Company Information Table 64. Pacific Biosciences of California Business Overview Table 65. Pacific Biosciences of California Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product Portfolio Table 67. Pacific Biosciences of California Recent Development Table 68. Qiagen Company Information Table 69. Qiagen Business Overview Table 70. Qiagen Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Qiagen Next-Generation Tumor Genetic Testing Product Portfolio Table 72. Qiagen Recent Development Table 73. Agilent Technologies Company Information Table 74. Agilent Technologies Business Overview Table 75. Agilent Technologies Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Agilent Technologies Next-Generation Tumor Genetic Testing Product Portfolio Table 77. Agilent Technologies Recent Development Table 78. Natera Company Information Table 79. Natera Business Overview Table 80. Natera Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Natera Next-Generation Tumor Genetic Testing Product Portfolio Table 82. Natera Recent Development Table 83. Bio Rad Laboratories Company Information Table 84. Bio Rad Laboratories Business Overview Table 85. Bio Rad Laboratories Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product Portfolio Table 87. Bio Rad Laboratories Recent Development Table 88. Myriad Genetics Company Information Table 89. Myriad Genetics Business Overview Table 90. Myriad Genetics Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Myriad Genetics Next-Generation Tumor Genetic Testing Product Portfolio Table 92. Myriad Genetics Recent Development Table 93. North America Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 94. North America Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 95. North America Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 96. North America Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 97. North America Next-Generation Tumor Genetic Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Next-Generation Tumor Genetic Testing Market Size by Country (2021-2026) Table 99. North America Next-Generation Tumor Genetic Testing Market Size by Country (2027-2032) Table 100. Europe Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 101. Europe Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 102. Europe Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 103. Europe Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 104. Europe Next-Generation Tumor Genetic Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Europe Next-Generation Tumor Genetic Testing Market Size by Country (2021-2026) Table 106. Europe Next-Generation Tumor Genetic Testing Market Size by Country (2027-2032) Table 107. China Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 108. China Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 109. China Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 110. China Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 111. Asia Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 112. Asia Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 113. Asia Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 114. Asia Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Next-Generation Tumor Genetic Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Asia Next-Generation Tumor Genetic Testing Market Size by Country (2021-2026) Table 117. Asia Next-Generation Tumor Genetic Testing Market Size by Country (2027-2032) Table 118. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 119. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 120. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2021-2026) Table 124. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2027-2032) Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Next-Generation Tumor Genetic Testing Product Image Figure 2. Global Next-Generation Tumor Genetic Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Next-Generation Tumor Genetic Testing Market Share by Type: 2025 VS 2032 Figure 4. Fluorescence In Situ Hybridization Image Figure 5. Polymerase Chain Reaction Image Figure 6. Microarray Technology Image Figure 7. Serum Proteomics Image Figure 8. Nucleic Acid Sequencing Image Figure 9. Global Next-Generation Tumor Genetic Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Next-Generation Tumor Genetic Testing Market Share by Application: 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Speciality Clinics Image Figure 13. Research Institutes Image Figure 14. Diagnostics Laboratories Image Figure 15. Biopharmaceutical Companies Image Figure 16. Global Next-Generation Tumor Genetic Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 18. Global Next-Generation Tumor Genetic Testing Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Next-Generation Tumor Genetic Testing Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Next-Generation Tumor Genetic Testing Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Next-Generation Tumor Genetic Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Type (2021-2032) Figure 25. Global Next-Generation Tumor Genetic Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Next-Generation Tumor Genetic Testing Revenue Market Share by Application (2021-2032) Figure 27. North America Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 28. North America Next-Generation Tumor Genetic Testing Market Share by Type (2021-2032) Figure 29. North America Next-Generation Tumor Genetic Testing Market Share by Application (2021-2032) Figure 30. North America Next-Generation Tumor Genetic Testing Market Share by Country (2021-2032) Figure 31. United States Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 32. Canada Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 34. Europe Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 35. Europe Next-Generation Tumor Genetic Testing Market Share by Type (2021-2032) Figure 36. Europe Next-Generation Tumor Genetic Testing Market Share by Application (2021-2032) Figure 37. Europe Next-Generation Tumor Genetic Testing Market Share by Country (2021-2032) Figure 38. Germany Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 39. France Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 41. Italy Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 42. Russia Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 44. China Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 45. China Next-Generation Tumor Genetic Testing Market Share by Type (2021-2032) Figure 46. China Next-Generation Tumor Genetic Testing Market Share by Application (2021-2032) Figure 47. Asia Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 48. Asia Next-Generation Tumor Genetic Testing Market Share by Type (2021-2032) Figure 49. Asia Next-Generation Tumor Genetic Testing Market Share by Application (2021-2032) Figure 50. Asia Next-Generation Tumor Genetic Testing Market Share by Country (2021-2032) Figure 51. Japan Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 55. India Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 56. Australia Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Share by Country (2021-2032) Figure 61. Brazil Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 66. UAE Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 68. Chile Next-Generation Tumor Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Fluorescence In Situ Hybridization
  • Polymerase Chain Reaction
  • Microarray Technology
  • Serum Proteomics
  • Nucleic Acid Sequencing
Applications
  • Hospitals
  • Speciality Clinics
  • Research Institutes
  • Diagnostics Laboratories
  • Biopharmaceutical Companies
Companies covered
  • Devyser
  • Agendia
  • Illumina
  • Personal Genome Diagnostics
  • Veracyte
  • Pacific Biosciences of California
  • Qiagen
  • Agilent Technologies
  • Natera
  • Bio Rad Laboratories
  • Myriad Genetics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Next-Generation Tumor Genetic Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Fluorescence In Situ Hybridization
  5. 1.2.3 Polymerase Chain Reaction
  6. 1.2.4 Microarray Technology
  7. 1.2.5 Serum Proteomics
  8. 1.2.6 Nucleic Acid Sequencing
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Next-Generation Tumor Genetic Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Speciality Clinics
  13. 1.3.4 Research Institutes
  14. 1.3.5 Diagnostics Laboratories
  15. 1.3.6 Biopharmaceutical Companies
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Next-Generation Tumor Genetic Testing Growth Trends by Region
  18. 1.5.1 Global Next-Generation Tumor Genetic Testing Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Next-Generation Tumor Genetic Testing Market Size by Region (2021-2026)
  20. 1.5.3 Next-Generation Tumor Genetic Testing Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Next-Generation Tumor Genetic Testing Market Dynamics
  1. 2.1 Next-Generation Tumor Genetic Testing Industry Trends
  2. 2.2 Next-Generation Tumor Genetic Testing Industry Drivers
  3. 2.3 Next-Generation Tumor Genetic Testing Industry Opportunities and Challenges
  4. 2.4 Next-Generation Tumor Genetic Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Next-Generation Tumor Genetic Testing Revenue by Company (2021-2026)
  2. 3.2 Global Next-Generation Tumor Genetic Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Next-Generation Tumor Genetic Testing Key Company Head office and Area Served
  4. 3.4 Global Next-Generation Tumor Genetic Testing Company, Product Type & Application
  5. 3.5 Global Next-Generation Tumor Genetic Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Next-Generation Tumor Genetic Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Next-Generation Tumor Genetic Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Next-Generation Tumor Genetic Testing Tier 1, Tier 2, and Tier 3
4 Next-Generation Tumor Genetic Testing Market by Type
  1. 4.1 Global Next-Generation Tumor Genetic Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Next-Generation Tumor Genetic Testing Market Size by Type (2021-2032)
  3. 4.3 Global Next-Generation Tumor Genetic Testing Market Size Share by Type (2021-2032)
5 Next-Generation Tumor Genetic Testing Market by Application
  1. 5.1 Global Next-Generation Tumor Genetic Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Next-Generation Tumor Genetic Testing Market Size by Application (2021-2032)
  3. 5.3 Global Next-Generation Tumor Genetic Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Devyser
  2. 6.1.1 Devyser Company Information
  3. 6.1.2 Devyser Business Overview
  4. 6.1.3 Devyser Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Devyser Next-Generation Tumor Genetic Testing Product Portfolio
  6. 6.1.5 Devyser Recent Developments
  7. 6.2 Agendia
  8. 6.2.1 Agendia Company Information
  9. 6.2.2 Agendia Business Overview
  10. 6.2.3 Agendia Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Agendia Next-Generation Tumor Genetic Testing Product Portfolio
  12. 6.2.5 Agendia Recent Developments
  13. 6.3 Illumina
  14. 6.3.1 Illumina Company Information
  15. 6.3.2 Illumina Business Overview
  16. 6.3.3 Illumina Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Illumina Next-Generation Tumor Genetic Testing Product Portfolio
  18. 6.3.5 Illumina Recent Developments
  19. 6.4 Personal Genome Diagnostics
  20. 6.4.1 Personal Genome Diagnostics Company Information
  21. 6.4.2 Personal Genome Diagnostics Business Overview
  22. 6.4.3 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product Portfolio
  24. 6.4.5 Personal Genome Diagnostics Recent Developments
  25. 6.5 Veracyte
  26. 6.5.1 Veracyte Company Information
  27. 6.5.2 Veracyte Business Overview
  28. 6.5.3 Veracyte Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Veracyte Next-Generation Tumor Genetic Testing Product Portfolio
  30. 6.5.5 Veracyte Recent Developments
  31. 6.6 Pacific Biosciences of California
  32. 6.6.1 Pacific Biosciences of California Company Information
  33. 6.6.2 Pacific Biosciences of California Business Overview
  34. 6.6.3 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product Portfolio
  36. 6.6.5 Pacific Biosciences of California Recent Developments
  37. 6.7 Qiagen
  38. 6.7.1 Qiagen Company Information
  39. 6.7.2 Qiagen Business Overview
  40. 6.7.3 Qiagen Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Qiagen Next-Generation Tumor Genetic Testing Product Portfolio
  42. 6.7.5 Qiagen Recent Developments
  43. 6.8 Agilent Technologies
  44. 6.8.1 Agilent Technologies Company Information
  45. 6.8.2 Agilent Technologies Business Overview
  46. 6.8.3 Agilent Technologies Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Agilent Technologies Next-Generation Tumor Genetic Testing Product Portfolio
  48. 6.8.5 Agilent Technologies Recent Developments
  49. 6.9 Natera
  50. 6.9.1 Natera Company Information
  51. 6.9.2 Natera Business Overview
  52. 6.9.3 Natera Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Natera Next-Generation Tumor Genetic Testing Product Portfolio
  54. 6.9.5 Natera Recent Developments
  55. 6.10 Bio Rad Laboratories
  56. 6.10.1 Bio Rad Laboratories Company Information
  57. 6.10.2 Bio Rad Laboratories Business Overview
  58. 6.10.3 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product Portfolio
  60. 6.10.5 Bio Rad Laboratories Recent Developments
  61. 6.11 Myriad Genetics
  62. 6.11.1 Myriad Genetics Company Information
  63. 6.11.2 Myriad Genetics Business Overview
  64. 6.11.3 Myriad Genetics Next-Generation Tumor Genetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Myriad Genetics Next-Generation Tumor Genetic Testing Product Portfolio
  66. 6.11.5 Myriad Genetics Recent Developments
7 North America
  1. 7.1 North America Next-Generation Tumor Genetic Testing Market Size (2021-2032)
  2. 7.2 North America Next-Generation Tumor Genetic Testing Market Size by Type
  3. 7.2.1 North America Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America Next-Generation Tumor Genetic Testing Market Share by Type (2021-2032)
  6. 7.3 North America Next-Generation Tumor Genetic Testing Market Size by Application
  7. 7.3.1 North America Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America Next-Generation Tumor Genetic Testing Market Share by Application (2021-2032)
  10. 7.4 North America Next-Generation Tumor Genetic Testing Market Size by Country
  11. 7.4.1 North America Next-Generation Tumor Genetic Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Next-Generation Tumor Genetic Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America Next-Generation Tumor Genetic Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America Next-Generation Tumor Genetic Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Next-Generation Tumor Genetic Testing Market Size (2021-2032)
  2. 8.2 Europe Next-Generation Tumor Genetic Testing Market Size by Type
  3. 8.2.1 Europe Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Next-Generation Tumor Genetic Testing Market Share by Type (2021-2032)
  6. 8.3 Europe Next-Generation Tumor Genetic Testing Market Size by Application
  7. 8.3.1 Europe Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Next-Generation Tumor Genetic Testing Market Share by Application (2021-2032)
  10. 8.4 Europe Next-Generation Tumor Genetic Testing Market Size by Country
  11. 8.4.1 Europe Next-Generation Tumor Genetic Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Next-Generation Tumor Genetic Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Next-Generation Tumor Genetic Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Next-Generation Tumor Genetic Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Next-Generation Tumor Genetic Testing Market Size (2021-2032)
  2. 9.2 China Next-Generation Tumor Genetic Testing Market Size by Type
  3. 9.2.1 China Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026)
  4. 9.2.2 China Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032)
  5. 9.2.3 China Next-Generation Tumor Genetic Testing Market Share by Type (2021-2032)
  6. 9.3 China Next-Generation Tumor Genetic Testing Market Size by Application
  7. 9.3.1 China Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026)
  8. 9.3.2 China Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032)
  9. 9.3.3 China Next-Generation Tumor Genetic Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Next-Generation Tumor Genetic Testing Market Size (2021-2032)
  2. 10.2 Asia Next-Generation Tumor Genetic Testing Market Size by Type
  3. 10.2.1 Asia Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Next-Generation Tumor Genetic Testing Market Share by Type (2021-2032)
  6. 10.3 Asia Next-Generation Tumor Genetic Testing Market Size by Application
  7. 10.3.1 Asia Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Next-Generation Tumor Genetic Testing Market Share by Application (2021-2032)
  10. 10.4 Asia Next-Generation Tumor Genetic Testing Market Size by Country
  11. 10.4.1 Asia Next-Generation Tumor Genetic Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Next-Generation Tumor Genetic Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Next-Generation Tumor Genetic Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Next-Generation Tumor Genetic Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Next-Generation Tumor Genetic Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst